Medical Device | October 10, 2025
Integris Medtech files DRHP with SEBI for IPO
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
Subscribe To Our Newsletter & Stay Updated
